Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 13 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-2.01 Insider Own61.73% Shs Outstand42.06M Perf Week3.17%
Market Cap214.23M Forward P/E- EPS next Y-1.42 Insider Trans0.00% Shs Float21.02M Perf Month1.04%
Income-125.55M PEG- EPS next Q-0.42 Inst Own30.23% Short Float2.78% Perf Quarter-12.56%
Sales0.00M P/S- EPS this Y16.83% Inst Trans-2.03% Short Ratio13.60 Perf Half Y14.71%
Book/sh3.84 P/B1.02 EPS next Y15.48% ROA-56.37% Short Interest0.59M Perf Year-30.23%
Cash/sh3.68 P/C1.06 EPS next 5Y30.10% ROE-65.04% 52W Range1.66 - 5.83 Perf YTD-8.67%
Dividend Est.- P/FCF- EPS past 5Y-43.14% ROI-55.51% 52W High-33.10% Beta1.55
Dividend TTM- Quick Ratio11.64 Sales past 5Y0.00% Gross Margin- 52W Low134.94% ATR (14)0.37
Dividend Ex-Date- Current Ratio11.64 EPS Y/Y TTM15.83% Oper. Margin0.00% RSI (14)49.66 Volatility8.05% 10.63%
Employees128 Debt/Eq0.08 Sales Y/Y TTM- Profit Margin- Recom3.00 Target Price4.67
Option/ShortYes / Yes LT Debt/Eq0.07 EPS Q/Q28.52% Payout- Rel Volume0.64 Prev Close4.03
Sales Surprise- EPS Surprise13.22% Sales Q/Q- EarningsMay 07 BMO Avg Volume43.04K Price3.90
SMA20-0.06% SMA50-4.90% SMA2007.85% Trades Volume27,408 Change-3.23%
Date Action Analyst Rating Change Price Target Change
Mar-13-24Initiated JMP Securities Mkt Outperform $7
Feb-20-24Downgrade H.C. Wainwright Buy → Neutral $5
Dec-19-23Downgrade Morgan Stanley Equal-Weight → Underweight $10 → $4
Nov-21-22Downgrade BofA Securities Neutral → Underperform $8 → $6
Sep-09-22Downgrade Morgan Stanley Overweight → Equal-Weight $19 → $11
Jul-29-22Initiated Jefferies Buy $9
Mar-15-22Downgrade BofA Securities Buy → Neutral $50 → $10
Feb-28-22Downgrade Barclays Overweight → Equal Weight $20 → $12
Oct-08-21Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-27-21Upgrade BofA Securities Neutral → Buy $60
Jun-03-24 07:01AM
May-09-24 07:01AM
May-07-24 01:53PM
Apr-09-24 04:35PM
04:45PM Loading…
Mar-05-24 04:45PM
Feb-29-24 04:05PM
Feb-15-24 04:05PM
Dec-11-23 09:34AM
Nov-03-23 08:42AM
Nov-01-23 04:10PM
Oct-14-23 12:30PM
Oct-04-23 12:00PM
08:30AM Loading…
Aug-29-23 08:30AM
Aug-17-23 09:56AM
Aug-03-23 08:00AM
Jul-10-23 08:13AM
Jun-02-23 11:36AM
May-31-23 08:30AM
May-28-23 08:11AM
May-18-23 07:00AM
May-17-23 04:08PM
May-08-23 08:30AM
Apr-27-23 08:30AM
Apr-11-23 08:30AM
Apr-07-23 09:34AM
Mar-18-23 06:48PM
Mar-16-23 12:06PM
08:30AM Loading…
Mar-15-23 08:30AM
Mar-01-23 08:30AM
Feb-09-23 09:05AM
Jan-30-23 09:38AM
Dec-24-22 07:05AM
Nov-25-22 08:06AM
Nov-14-22 08:00AM
Oct-18-22 08:00AM
Sep-06-22 08:00AM
Aug-23-22 06:39AM
Aug-10-22 09:25AM
Aug-09-22 08:00AM
Jul-05-22 09:22PM
Jun-22-22 09:55AM
May-25-22 06:35AM
May-10-22 08:00AM
Mar-16-22 07:30AM
Mar-11-22 08:00AM
Mar-09-22 08:05AM
Feb-11-22 07:00AM
Jan-04-22 07:00AM
Dec-24-21 12:38AM
Dec-18-21 12:38AM
Dec-16-21 09:41AM
Dec-15-21 07:15PM
Dec-08-21 08:47AM
Nov-23-21 07:00AM
Nov-19-21 11:51AM
Nov-12-21 08:00AM
Nov-08-21 09:00AM
Oct-18-21 08:24PM
Oct-07-21 03:12PM
Sep-25-21 10:06AM
Sep-09-21 07:07PM
Sep-02-21 07:00AM
Aug-12-21 07:30AM
Aug-11-21 06:49AM
Jul-19-21 07:00AM
May-13-21 07:15AM
May-11-21 07:30AM
May-05-21 07:00AM
Apr-20-21 07:42AM
Mar-16-21 08:00AM
Mar-03-21 07:00AM
Jan-11-21 06:20PM
Jan-07-21 12:12AM
Jan-04-21 04:16PM
Dec-25-20 04:01AM
Dec-15-20 11:42PM
Nov-10-20 07:30AM
Oct-02-20 08:00PM
Oct-01-20 11:57AM
Sep-30-20 07:00AM
Sep-29-20 04:05PM
Sep-25-20 02:31PM
Sep-24-20 08:50PM
Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.